{"title": "Infographic: Vaccine development for infectious disease", "author": "Tiffany Garbutt; PhD", "url": "https://www.drugdiscoverynews.com/vaccine-development-for-infectious-disease-15228", "hostname": "drugdiscoverynews.com", "description": "Researchers are conducting the first long-term perspective study to understand the immune response to COVID-19 long after initial infection.", "sitename": "Drug Discovery News Magazine", "date": "2021-08-20", "cleaned_text": "for infectious disease Vaccine development for infectious diseases gives rise to new vaccine approaches and accelerated development and approval timelines. Traditional vaccine development and approval take approximately 10-15 years. The vaccine development timeline for SARS-CoV-2 continues to accelerate as new discoveries and approvals happen every day, but the accelerated vaccine development timeline for the novel SARS-CoV-2 virus is not unique. Throughout history, the world has grappled with the emergence of other viral epidemics that have required the flexibility of vaccine development and approval timelines. In this infographic, discover the traditional vaccine development timeline and novel approaches to vaccine development for several infectious diseases. [Download the "}